On January 16, 2026, Jaguar Health, Inc. engaged in agreements to exchange royalty interests with Iliad and Streeterville, resulting in $1,187,914.07 and $850,000 reductions in their respective royalty obligations, while issuing warrants to purchase a total of 9,913,696 shares of Common Stock.